NEW YORK (GenomeWeb News) - Third Wave Technologies said today that it has secured a five-year, $25 million line of credit with healthcare investment company Deerfield Management.
 
Third Wave said it may use the extra capital to market its human papillomavirus tests.
 
The company said any funds it borrows under the facility will have a 7.75 percent interest rate, and an annual two percent non-usage fee will be assessed on the amount the company does not draw.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.